Abiopharma

Clinical trial NCT07498426: start date: 2026-05-29 → 2026-06-03.

Clinical trial NCT05867121 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-03-16 3. primary completion date: 2026-06-30 → 2026-03-16

Clinical trial NCT06899750: primary completion date: 2026-03-01 → 2026-10-01.

Clinical trial NCT06312189 updates: 1. completion date: 2026-04-01 → 2028-04-01 2. primary completion date: 2026-04-01 → 2028-04-01

Clinical trial NCT06365723 updates: 1. completion date: 2027-11-30 → 2028-11-30 2. primary completion date: 2027-11-30 → 2028-11-30

Clinical trial NCT07214766 updates: 1. enrollment: 312 → 331 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06035744 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2028-06-01 → 2026-06-16 3. primary completion date: 2028-06-01 → 2026-06-16 4. enrollment: 86 → 23 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07613294 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-02

Clinical trial NCT06529822 updates: 1. completion date: 2033-03-31 → 2034-06-30 2. primary completion date: 2028-10-31 → 2030-01-31 3. enrollment: 32 → 64 participants

Clinical trial NCT05389449 updates: 1. completion date: 2026-07-31 → 2026-08-24 2. primary completion date: 2026-07-31 → 2026-08-24